It is important to further improve the efficiency of hepatitis B core antigen-pulsed monocyte-derived dendritic cell (core-DC) vaccine in clinical immunotherapy for chronic hepatitis B virus (HBV) infection in humans. Our study shows that CpG-treated plasmacytoid dendritic cells (pDCs) can efficient...
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 129(2008), 2 vom: 11. Nov., Seite 295-303
|
|---|
| Auteur principal: |
Chen, Weiwei
(Auteur) |
|---|
| Autres auteurs: |
Zhang, Zheng,
Shi, Ming,
Chen, Liangen,
Fu, Junliang,
Shi, Feng,
Zhang, Bing,
Zhang, Hui,
Jin, Lei,
Wang, Fu-Sheng |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2008
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Journal Article
Research Support, Non-U.S. Gov't
CPG-oligonucleotide
Hepatitis B Core Antigens
Interferon-alpha
Oligodeoxyribonucleotides
Tumor Necrosis Factor-alpha
Interferon-gamma
82115-62-6 |
|---|